Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -288 | -1,249 | -1,079 | -669 | -7,810 |
| Depreciation Amortization | 7,901 | 5,909 | 3,960 | 1,979 | 8,812 |
| Income taxes - deferred | -330 | -498 | -303 | -53 | -23 |
| Accounts receivable | -4,294 | -727 | 323 | 584 | 3,105 |
| Accounts payable and accrued liabilities | 2,454 | N/A | 1,629 | -245 | 1,491 |
| Other Working Capital | -10,190 | -6,153 | -2,905 | -1,188 | 4,106 |
| Other Operating Activity | 6,009 | 3,863 | 180 | 629 | -350 |
| Operating Cash Flow | $1,262 | $1,145 | $1,805 | $1,037 | $9,331 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,195 | -837 | -357 | -151 | -1,152 |
| Purchase Sale Intangibles | -150 | -150 | -150 | -150 | -250 |
| Other Investing Activity | -150 | -150 | -150 | -150 | -250 |
| Investing Cash Flow | $-1,345 | $-987 | $-507 | $-301 | $-1,402 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,250 | 2,500 | N/A | N/A | 61,315 |
| Debt Repayment | -4,200 | -5,500 | -4,000 | -500 | -66,912 |
| Common Stock Issued | 3,314 | 2,909 | 2,759 | 1,924 | 669 |
| Other Financing Activity | -3,616 | -2,755 | -2,092 | -4,565 | -3,039 |
| Financing Cash Flow | $-252 | $-2,846 | $-3,333 | $-3,141 | $-7,967 |
| Exchange Rate Effect | -161 | -81 | -45 | -97 | 20 |
| Beginning Cash Position | 8,317 | 8,317 | 8,317 | 8,317 | 8,335 |
| End Cash Position | 7,821 | 5,548 | 6,237 | 5,815 | 8,317 |
| Net Cash Flow | $-496 | $-2,769 | $-2,080 | $-2,502 | $-18 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,262 | 1,145 | 1,805 | 1,037 | 9,331 |
| Capital Expenditure | -1,195 | -837 | -357 | -151 | -1,152 |
| Free Cash Flow | 67 | 308 | 1,448 | 886 | 8,179 |